Mid cap
Nesco's revenue grew 27%, but profit barely kept pace.
Top-line expansion is solid. The gap between sales and profit growth tells the real story.
Wabag sees ₹17,200 cr backlog, plans to double maintenance revenue share
Record backlog and ₹950 cr cash cushion give the water-treatment firm runway for its push into semiconductors and green hydrogen.
Sudarshan Chemical confirms FY26 profit, recommends ₹5 dividend
The board approved audited results the market already saw. The only fresh number is a ₹5 per-share payout.
Sigma Advanced Systems' annual profit is 92% a one-off land sale
Standalone PAT hit ₹200.6 crore, but ₹184.6 crore of it was a property disposal. The core business is a fraction of the headline number.
Nesco's ₹932 cr revenue was already priced in. The real story is the ₹7 dividend.
Annual results met the trajectory flagged in Q3. The dividend increase is the only new cash signal.
Sudarshan Chemical finalises FY26 results, declares ₹5 dividend
The board approved audited FY2026 numbers, which were already in the public domain. The cash payout is the only fresh detail.
Eureka Forbes reiterates FY27 margin guidance; the transcript adds nothing new
The full Q4 FY26 earnings call transcript restates what was already disclosed in the board outcomes and press release. Management's guidance to hold margins in FY27 was communicated at the time of the results.
Sudarshan's Q4 profit jumps to ₹120 cr as Heubach deal pays off
Standalone profit surged over five-fold to ₹120.4 crore, driven by improved margins and the post-acquisition earnings boost.
Anupam Rasayan cuts EBITDA margin guidance by 200 bps, flags consolidation drag
Management now expects an EBITDA margin of 23-24% for FY26, down from 25%, citing the Bliss GVS Pharma consolidation and phasing effects. The ₹14,000 crore order book underpins a 20-30% annual growth outlook.
Campus Activewear bets on sneakers and stores for next growth leg
The sneaker portfolio doubled last year and now anchors Campus's premium push. The company is ramping up capacity and planning a store blitz after a flat year.
Poly Medicure walks back PendraCare revenue, renal growth targets
The post-results call corrected a key metric downward and cut a growth forecast, while acquisitions weighed on margins.
Suprajit's FY26 profit grows 8.7%; consolidated surge is an acquisition echo
Standalone growth is steady. The consolidated profit jump of 84% is a base effect from the SCS deal's first full year in the accounts.
Pine Labs posts first full-year profit as transaction volumes hit $194B
Net profit of ₹113 crore marks a ₹258 crore swing from last year's loss. Revenue grew 19% to ₹2,711 crore as UPI volumes surged 68%.
Kovai fixes a tax math error, lifting Q4 profit by ₹3.67 cr
A calculation mistake in the final quarter's tax expense added 6.1% to net profit. The full-year results are untouched.
Blue Jet shelves ₹1,000 cr Vizag plan, CDMO pipeline shrinks to 4 projects
Management pivoted capex away from a flagship plant and disclosed a CDMO pipeline of just 4-5 projects, down from 20 active RFPs last quarter.
Suprajit's FY26 profit jumps 84% as SCS acquisition fully consolidates
The auto-component maker's first full-year results with SCS on the books show strong headline growth. Standalone business grew at a modest pace.
KSH International's quarterly revenue nearly doubled on copper-wire demand
The winding-wires maker's Q4 revenue hit ₹1,018 cr as capacity expansion and copper prices drove a near-doubling of top-line growth.
Sanofi India hires PwC as auditor after predecessor's exit
The consumer-healthcare unit replaces Kalyaniwalla & Mistry with a Big Four firm for a five-year term, pending shareholder sign-off.
ABFRL's Q4 profit surges on Pantaloons and TMRW
Revenue rose 16% to ₹1,990 crore, but the real story is a 410 bps margin jump to 15.7%, fueled by strong growth in Pantaloons and the digital-first portfolio.
ICRA signals buyback as cash reserves top ₹700 cr
The credit-ratings agency grew revenue 20.4% in FY26 and is now weighing a return of over ₹700 crore to shareholders.
KSH International confirms a steady FY26. No new signals.
Audited results for Q4 and FY26 are a procedural filing. The numbers match the known growth story from the IPO and capacity build-out.
ABFRL cuts losses as Pantaloons and TMRW drive 16% revenue jump
Operating profit rose 29% to ₹229 crore, and margins widened 120 basis points. The net loss, however, remains at ₹164 crore.
Pine Labs posts first full-year profit as cash flow surges 8x
The payments processor swung from a ₹145 crore loss to a ₹113 crore profit in FY26, with operating cash flow hitting ₹395 crore.
Saatvik pushes Odisha cell plant to H2 FY27, plans ₹1,700 cr capex
Management blamed Q4 margin compression on commodity prices and a weak rupee. The ₹1,700 cr spending plan for FY27 is a mix of debt and accruals.
KSH International's quarterly revenue nearly doubles on winding-wire demand
Q4 revenue hit ₹10,183 million, up from ₹5,078 million a year ago, as the newly listed maker of winding wires capitalised on strong copper-wire demand.